It is counter productive for pc to bad mouth GSK. He may yet need to talk with them re LANI. If that turns out to be the unfortunate case, positive comments re GSK will not go astray.
The jury is still out on pc. Let us all hope that he can establish BTA in a continuing solid and profitable position. Past experience is still a cause for a lot of concern.
